The quality improvement drive to address drug shortages
Persistent drug shortages are mostly attributable to manufacturing quality problems, but the economics of low-margin generic manufacturing challenge the industry
Managing government pricing programs
When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences
The evolving CSO landscape
Outsourced field sales is becoming only part of what CSOs are offering their pharma clients
A conversation with Phil Hagerman, Diplomat Pharmacy
Veeva, Cegedim announce new partnerships and IT alliances in pharma sales force automation
Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management
Managing third-party risks in the life sciences industry
Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners
The Price of Global Health
Defining 'market access'
Practice Fusion EHR and OPTIMIZERx team up to expand sample, coupon access
Compliance issues around sampling will be featured at upcoming conference
'Precision medicine' gets a nod in President Obama's State of the Union address
Details will come out later on what the new initiative entails
PBMs push into a bigger share of top drug retailers, says Pembroke Consulting
While traditional retail chains still dominate, the focus by PBMs on specialty distribution is raising their presence among top retailers
Energetic M&A activity in 2014 will continue into 2015, predicts EY
Industry 'Firepower Index' shows increased capacity for deal-making, but specialty pharma is pushing Big Pharma to the side
Life sciences commited $15 billion in new construction in the US in 2014, up 25% over 2013
Survey of construction projects and facility upgrads finds 739 projects initiated
Practice Fusion EHR and OptimizeRx team up to expand sample, coupon access
Almost a third of newly approved drugs are cold chain products
Key oncolytics will require cold chain storage; room-temp products still have varying temperature requirements
Veeva, Cegedim announce new partnerships and IT alliances in pharma salesforce automation
Publicis Touchpoint, a leading CSO, does a deal with Cegedim Relationship Management
Is BioLife Solutions cornering the market for handling human cells and tissues?
Company hires Kevin O'Donnell, cold-chain expert, to build out its Biologistex shipping service
Dohmen acquires Siren Interactive, a rare diseases agency
Acquisition builds on Dohmen's rare-disease business
With acquisition of Optum Health assets, Mapi Group bids to capture health economics consulting work globally
Mapi Group casts itself as a leading 'health research and commercialization' player
Walgreens-Alliance Boots tieup is formally approved
So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape
FDA gives pharma industry a breather on DSCSA traceability requirements
Enforcement actions are postponed to May 1 under new guidance
Hepatitis C therapies multiply and price concessions appear behind the scenes
Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount
Nurses remain the top most-trusted profession, says annual Gallup poll
Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors
UPS Healthcare Logistics picks up an asset in Poland
Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe
Entries for the 2014 Compliance Package of the Year are now being accepted
Annual award promotes patient-adherence aspects of unit-dose packaging
Doximity crosses 50% line of engagement with physician population
'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
FDA is heading for a strong year in new drug approvals
Orphan drug approvals, at 15 so far, sets a record
Industry traceability activity ramps up, with some companies already preparing for 2017
DSCSA's Jan 1 deadline is the immediate worry, says HDMA
Here comes a national database of drug wholesalers and 3PLs
FDA issues guidance for filings from such organizations under the Drug Supply Chain Security Act (DSCSA)
Marken and BDI Pharma add to US cold-chain capacity
New operations center at JFK airport for Marken; new distribution center in Texas for BDI
Meetings lineup for cold chain conferences in early 2015
Cargo, logistics and packaging interests are represented
